Clinical Trial Update: PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella

View source ↗

Summary

The PMCF study evaluating the safety, performance and clinical benefits data of the NexGen TM Augmentation Patella has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• NexGen TM Augmentation Patella

Snippet

Sponsor: Zimmer Biomet | Conditions: Rheumatoid Arthritis, Non-inflammatory Degenerative Joint Disease | Status: WITHDRAWN